MedTrace Logo

Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV

NCT03296202 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 7200

Last updated 2025-02-21

No results posted yet for this study

Summary

HIV infection is now a chronic disease in countries where antiretroviral treatments (ART) are largely available. Long-term follow-up is required to describe and understand the evolution of morbidities and complications as well as new treatments side effects.

The main objective of the cohort is to describe and study the evolution of HIV infection in ART-treated individuals.

Conditions

  • HIV Infections
  • Antiretroviral Agents

Sponsors & Collaborators

  • National Agency for Research on AIDS and Viral Hepatitis (ANRS)

    collaborator OTHER

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • French Ministry of Health through the COREVIH Aquitaine

    collaborator UNKNOWN

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Linda WITTKOP, MD, PhD · ISPED - CHU de Bordeaux

  • Fabrice BONNET, Prof · University Hospital, Bordeaux

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-18
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03296202 on ClinicalTrials.gov